104 related articles for article (PubMed ID: 7824053)
1. Neurofibrillary tangles have no obligatory predilection for acetylcholinesterase-rich neurons.
Mesulam MM; Brimijoin S; Geula C
Neurobiol Aging; 1994; 15(5):615-9. PubMed ID: 7824053
[TBL] [Abstract][Full Text] [Related]
2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
Wright CI; Geula C; Mesulam MM
Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease.
Heckers S; Geula C; Mesulam MM
Neurobiol Aging; 1992; 13(4):455-60. PubMed ID: 1508295
[TBL] [Abstract][Full Text] [Related]
4. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
Coleman AE; Geula C; Price BH; Mesulam MM
Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
[TBL] [Abstract][Full Text] [Related]
5. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.
Gomez-Ramos P; Mufson EJ; Moran MA
Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829
[TBL] [Abstract][Full Text] [Related]
6. Acetylcholinesterase provides deeper insights into Alzheimer's disease.
Shen ZX
Med Hypotheses; 1994 Jul; 43(1):21-30. PubMed ID: 7968717
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease.
Mizukami K; Akatsu H; Abrahamson EE; Mi Z; Ikonomovic MD
Neuropathology; 2016 Apr; 36(2):135-45. PubMed ID: 26293308
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
Wright CI; Geula C; Mesulam MM
Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
[TBL] [Abstract][Full Text] [Related]
9. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease.
Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N
J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
Shimohama S; Perry G; Richey P; Praprotnik D; Takenawa T; Fukami K; Whitehouse PJ; Kimura J
Brain Res; 1995 Jan; 669(2):217-24. PubMed ID: 7712177
[TBL] [Abstract][Full Text] [Related]
11. Cholinesterases and the pathology of Alzheimer disease.
Geula C; Mesulam MM
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():23-8. PubMed ID: 8534419
[TBL] [Abstract][Full Text] [Related]
12. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
Carson KA; Geula C; Mesulam MM
Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
[TBL] [Abstract][Full Text] [Related]
13. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease.
Callahan LM; Coleman PD
Neurobiol Aging; 1995; 16(3):311-4. PubMed ID: 7566340
[TBL] [Abstract][Full Text] [Related]
14. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease.
Arriagada PV; Marzloff K; Hyman BT
Neurology; 1992 Sep; 42(9):1681-8. PubMed ID: 1307688
[TBL] [Abstract][Full Text] [Related]
15. Neurofibrillary degeneration of cholinergic and noncholinergic neurons of the basal forebrain in Alzheimer's disease.
Rasool CG; Svendsen CN; Selkoe DJ
Ann Neurol; 1986 Oct; 20(4):482-8. PubMed ID: 3539000
[TBL] [Abstract][Full Text] [Related]
16. Cholinesterases in normal and Alzheimer's disease primary olfactory gyrus.
Hamodat H; Cash MK; Fisk JD; Darvesh S
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):571-583. PubMed ID: 28644906
[TBL] [Abstract][Full Text] [Related]
17. Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration.
Leroy K; Yilmaz Z; Brion JP
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):43-55. PubMed ID: 17239007
[TBL] [Abstract][Full Text] [Related]
18. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
Sheng JG; Mrak RE; Griffin WS
J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
[TBL] [Abstract][Full Text] [Related]
19. Glycogen synthase kinase 3 alpha and 3 beta do not colocalize with neurofibrillary tangles.
Harr SD; Hollister RD; Hyman BT
Neurobiol Aging; 1996; 17(3):343-8. PubMed ID: 8725894
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration.
Pei JJ; Braak H; Gong CX; Grundke-Iqbal I; Iqbal K; Winblad B; Cowburn RF
Acta Neuropathol; 2002 Oct; 104(4):369-76. PubMed ID: 12200623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
